TABLE OF CONTENTS 
1.0 Objectives 
2.0 Rationale for Current Protocol: Scientific and 
Therapeutic Justification (Includes Brief Study 
Outline) 
3 . 0 Background 
4.0 Patient Eligibility 
5.0 Treatment Plan 
6 . 0 Concurrent Treatment and Supportive Care 
7.0 Autologous Bone Marrow and Peripheral Blood Stem 
Cell Harvesting, Cell Separation and 
Cryopreservation of Cells 
8.0 Pre-study/treatment Evaluation 
9 . 0 On-study Evaluation 
10.0 Toxicity Monitoring 
11.0 Dose Modifications 
12.0 Hazards and Discomforts 
13.0 Response Criteria 
14.0 Criteria for Removal from Study 
15.0 Biostatistical Analysis 
16.0 References 
17.0 Appendices 
A. ECOG Performance Status 
B. Dartmouth Bone Marrow Transplant Criteria 
C. Radiotherapy Guidelines and Information 
D. Drug Information 
E. Interferon Toxicity Criteria 
F. GM-CSF Toxicity Criteria 
G. Treatment Flow Diagram 
H. Study Evaluation Flow Diagrams 
18.0 Informed Consent From for Protocol 
[142] 
Recombinant DNA Research, Volume 16 
